X4 Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
XFOR
CUSIP
98420X103
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 98420X103 since 12/18/2024, largest first.

Filer % of Class Filed
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Vanguard Group Inc 13G/A 4.8% 1/31/2025
Event 12/31/2024
Orbimed Advisors LLC 13G/A 1.7% 8/14/2025
Event 6/30/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 1 3.23 M $9.38M
2026 Q2 1 3.23 M $15.1M
2026 Q1 2 3.47 M $14.3M
2025 Q4 3 3.51 M $14.0M
2025 Q3 2 2.51 M $8.57M
2025 Q2 2 653 k $1.24M
2025 Q1 95 98.5 M $23.5M
2024 Q4 92 99.8 M $73.2M
2024 Q3 101 101 M $67.5M
2024 Q2 103 102 M $59.1M
2024 Q1 101 103 M $144M
2023 Q4 96 97.3 M $81.6M
2023 Q3 92 112 M $123M
2023 Q2 100 113 M $219M
2023 Q1 61 61.5 M $53.6M
2022 Q4 56 60.6 M $60.2M
2022 Q3 61 39.1 M $66.9M
2022 Q2 52 16.1 M $15.5M
2022 Q1 59 16.3 M $28.7M
2021 Q4 54 17.6 M $40.2M
2021 Q3 53 16.2 M $85.7M
2021 Q2 65 16.6 M $108M
2021 Q1 63 16.1 M $139M
2020 Q4 55 10.5 M $67.4M
2020 Q3 54 10.2 M $69.3M
2020 Q2 58 11.0 M $102M
2020 Q1 51 11.3 M $113M
2019 Q4 55 11.0 M $118M
2019 Q3 51 7.74 M $98.4M
2019 Q2 45 7.61 M $114M
2019 Q1 31 1.79 M $31.1M